Just caught Brown-Forman's Q3 earnings and they actually managed to mark a solid beat on both top and bottom lines, which is refreshing given how tough the environment has been. EPS came in at 58 cents, up 1% YoY and beat the consensus of 48 cents. Sales hit $1.056 billion, up 2% reported but organic growth was just 1% - so basically flat when you strip out the noise from acquisitions. The stock's down 12.9% over three months though, so the market's clearly not that impressed.

What's interesting is the margin story. Gross margin expanded 80 bps to 60.6%, but that's mostly from M&A effects. On an organic basis, margins actually compressed 1%, which tells you pricing power is limited and costs are creeping up. Operating income jumped 21% reported but fell 9% organically - classic accounting trick.

Geographically, it's a mixed bag. US sales are struggling, down 1% organically with Jack Daniel's volumes soft. But emerging markets are firing on all cylinders - up 15% organically, especially Brazil and Turkey. Travel retail also holding up well at 7% organic growth.

Brand-wise, the New Mix RTD line is their bright spot, surging 34% organically with strong Mexico traction. But tequila's getting hammered - Herradura down 12% organically as the category gets competitive. Jack Daniel's Tennessee Whiskey itself is losing momentum too.

Management's still guiding for low-single digit organic sales decline in FY26, so they're basically bracing for more headwinds. Free cash flow was solid at $628 million though, and they just approved another $400 million buyback. Dividend's been raised 42 years straight, so at least shareholders get something consistent from this mark of a company.